Literature DB >> 19914633

Prevalence of developmental disabilities and receipt of special education services among children with an inborn error of metabolism.

Kimberly Powell1, Kim Van Naarden Braun, Rani Singh, Stuart K Shapira, Richard S Olney, Marshalyn Yeargin-Allsopp.   

Abstract

OBJECTIVE: To examine the presence of developmental disabilities and receipt of special education services in children with an inborn error of metabolism. STUDY
DESIGN: The study population was children born from 1988 through 2001 in whom a metabolic disorder was diagnosed after identification by newborn screening (n = 97) or after clinical identification (n = 34). These children were linked to the Metropolitan Atlanta Development Disability Surveillance Program (MADDSP) and Special Education Database of Metropolitan Atlanta (SEDMA) to determine developmental outcomes at 8 years of age and 3 through 10 years of age, respectively. Medical and educational records were examined to consider factors contributing to developmental outcomes.
RESULTS: Of 97 children with a metabolic disorder identified with newborn screening, 12 (12.4%) were identified by SEDMA as receiving special education services and 2 (2.7%) were identified by MADDSP as having a developmental disability. Of the 34 children with a clinically identified metabolic disorder, 8 (23.5%) were identified with SEDMA, and 5 (17.2%) were identified with a MADDSP developmental disability.
CONCLUSION: Early identification and treatment have been successful in limiting the impact of severe developmental disabilities. Continued surveillance and research are needed to monitor less severe developmental outcomes. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19914633     DOI: 10.1016/j.jpeds.2009.09.068

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

Review 1.  Ensuring the Life-Span Benefits of Newborn Screening.

Authors:  Alex R Kemper; Coleen A Boyle; Jeffrey P Brosco; Scott D Grosse
Journal:  Pediatrics       Date:  2019-11-06       Impact factor: 7.124

2.  Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.

Authors:  Sarah L Logan; Laura Carpenter; R Scott Leslie; Kelly S Hunt; Elizabeth Garrett-Mayer; Jane Charles; Joyce S Nicholas
Journal:  J Autism Dev Disord       Date:  2014-11

3.  Exclusion of progressive brain disorders of childhood for a cerebral palsy monitoring system: a public health perspective.

Authors:  Richard S Olney; Nancy S Doernberg; Marshalyn Yeargin-Allsop
Journal:  J Registry Manag       Date:  2014

4.  Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.

Authors:  Sarah L Logan; Laura Carpenter; R Scott Leslie; Elizabeth Garrett-Mayer; Kelly J Hunt; Jane Charles; Joyce S Nicholas
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.